IBM and life sciences company NetGenics, Inc. today announced they have expanded their partnership, which started in 1999, to include an agreement for NetGenics to re-sell IBM’s new DiscoveryLink(1) data integration software.
According to the companies, DiscoveryLink can accelerate drug discovery by helping researchers merge information — from many sources, including public and private databases, and in diverse data formats and file types — using a single query. Under the terms of the agreement, NetGenics can integrate DiscoveryLink into its DiscoveryCenter product, as well as re-distribute the technology on a stand-alone basis.
NetGenics says its DiscoveryCenter(2) is a comprehensive life science informatics integration package, designed to maximize the use of internal and external information resources. DiscoveryCenter combines NetGenics’ software components, public and private data sources and application software with consulting services, helping pharmaceutical and biotechnology companies to tackle complex data integration and analysis problems.